Advertisement
Original article| Volume 44, 102300, September 2020

Coffee consumption is not associated with risk of multiple sclerosis: A Mendelian randomization study

  • Author Footnotes
    1 These authors contributed equally to this work.
    Hui Lu
    Correspondence
    Corresponding author at: 45 Changchun Street, Xicheng District, Beijing, China.
    Footnotes
    1 These authors contributed equally to this work.
    Affiliations
    Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work.
    Peng-Fei Wu
    Footnotes
    1 These authors contributed equally to this work.
    Affiliations
    Hunan Provincial Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China

    Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
    Search for articles by this author
  • Wan Zhang
    Affiliations
    Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA

    Department of Biology, College of Arts & Sciences, Boston University, Massachusetts, USA
    Search for articles by this author
  • Kun Xia
    Affiliations
    Hunan Provincial Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China

    Center for Excellence in Brain Science and Intelligences Technology (CEBSIT), Shanghai, China
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work.

      Highlights

      • The results of previous studies on whether coffee consumption can decrease the risk of multiple sclerosis are conflicting.
      • We found no evidence for the casual effect of coffee consumption on the risk of multiple sclerosis using Mendelian randomization analysis.
      • Further well-designed genetic-epidemiological studies investigating the effect of coffee intake on the disease course, such as relapse and progression, are warranted.

      Abstract

      Objective

      . Coffee consumption has been suggested to decrease the risk of multiple sclerosis (MS). In this study, we aim to investigate the causal effect of coffee consumption on risk of MS by Mendelian randomization (MR) approaches.

      Methods

      . Through a genome-wide association study including 375,833 participants from UK Biobank, we obtained single-nucleotide polymorphisms (SNPs) associated with habitual coffee consumption (P < 5 × 10−8). Summary-level data for MS were obtained from a meta-analysis, incorporating 14,802 subjects with MS and 26,703 healthy controls of European ancestry, which was conducted by the International Multiple Sclerosis Genetics Consortium. MR analyses were performed using inverse-variance-weighted method, weighted median estimator, and MR-Egger regression. Additional analyses were further performed using MR-Egger intercept and Cochran's Q statistic to verify the robustness of our findings.

      Results

      . Nine coffee-associated SNPs were selected as instrumental variables. We failed to detect a causal effect of coffee consumption on MS risk (odds ratio, 1,00; 95% confidence interval, 0.98-1.01; P = 0.48). In the main MR analysis. Consistent results were yielded in sensitivity analyses using the weighted median and MR-Egger methods, and no horizontal pleiotropy (P = 0.49) was identified.

      Conclusion

      . Our MR results indicated that coffee consumption might not be causally associated with risk of MS occurrence. Further well-designed genetic-epidemiological studies investigating the effect of coffee intake on the disease course, such as relapse and progression, are warranted.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bae S.C.
        • Lee Y.H.
        Coffee consumption and the risk of rheumatoid arthritis and systemic lupus erythematosus: a Mendelian randomization study.
        Clin. Rheumatol. 2018; 37: 2875-2879
        • Brion M.J.
        • Shakhbazov K.
        • Visscher P.M.
        Calculating statistical power in Mendelian randomization studies.
        Int. J. Epidemiol. 2013; 42: 1497-1501
        • Chen G.Q.
        • Chen Y.Y.
        • Wang X.S.
        • et al.
        Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats.
        Brain Res. 2010; 1309: 116-125
        • Cornelis M.C.
        • Kacprowski T.
        • Menni C.
        • et al.
        Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior.
        Hum. Mol. Genet. 2016; 25: 5472‐5482
        • Davies N.M.
        • Holmes M.V.
        • Davey S.G.
        Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.
        BMJ. 2018; 362: k601
        • Fraussen J.
        • de Bock L.
        • Somers V.
        B cells and antibodies in progressive multiple sclerosis: contribution to neurodegeneration and progression.
        Autoimmun. Rev. 2016; 15: 896-899
        • Freedman N.D.
        • Park Y.
        • Abnet C.C.
        • Hollenbeck A.R.
        • Sinha R.
        Association of coffee drinking with total and cause-specific mortality.
        N. Engl. J. Med. 2012; 366: 1891-1904
        • Gage S.H.
        • Jones H.J.
        • Taylor A.E.
        • Burgess S.
        • Zammit S.
        • Munafò M.R.
        Investigating causality in associations between smoking initiation and schizophrenia using Mendelian randomization.
        Sci. Rep. 2017; 7: 40653
      1. Goldenberg, M.M., 2012. Multiple sclerosis review. P. T.37 (3), 175-184.

        • Gunter M.J.
        • Murphy N.
        • Cross A.J.
        • et al.
        Coffee drinking and mortality in 10 European Countries: a multinational cohort study.
        Ann. Intern. Med. 2017; 167: 236-247
        • Hedström A.K.
        • Mowry E.M.
        • Gianfrancesco M.A.
        • et al.
        High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.
        J. Neurol. Neurosurg. Psychiatry. 2016; 87: 454-460
        • Hemani G.
        • Zheng J.
        • Elsworth B.
        • et al.
        The MR-Base platform supports systematic causal inference across the human phenome.
        Elife 2018. 2018; 7: e34408
        • Hernán M.A.
        • Takkouche B.
        • Caamaño-Isorna F.
        • Gestal-Otero J.J.
        A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease.
        Ann. Neurol. 2002; 52: 276-284
        • Jahromi S.R.
        • Toghae M.
        • Jahromi M.J.
        • Aloosh M.
        Dietary pattern and risk of multiple sclerosis.
        Iran J. Neurol. 2012; 11: 47-53
        • Jakimovski D.
        • Guan Y.
        • Ramanathan M.
        • Weinstock-Guttman B.
        • Zivadinov R.
        Lifestyle-based modifiable risk factors in multiple sclerosis: review of experimental and clinical findings.
        Neurodegener. Dis. Manage. 2019; 9: 149-172
        • Karlson E.W.
        • Mandl L.A.
        • Aweh G.N.
        • Grodstein F.
        Coffee consumption and risk of rheumatoid arthritis.
        Arthritis Rheum. 2003; 48: 3055-3060
        • Lee Y.H.
        • Bae S.C.
        • Song G.G.
        Coffee or tea consumption and the risk of rheumatoid arthritis: a meta-analysis.
        Clin. Rheumatol. 2014; 33: 1575-1583
        • Lo J.
        • Chan L.
        • Flynn S.
        A systematic review of the incidence, prevalence, costs, and activity/work limitations of amputation, osteoarthritis, rheumatoid arthritis, back pain, multiple sclerosis, spinal cord injury, stroke, and traumatic brain injury in the united states: a 2019 update.
        Arch. Phys. Med. Rehabil. 2020; (S0003-9993(20)30216-1)
        • Loftfield E.
        • Cornelis M.C.
        • Caporaso N.
        • Yu K.
        • Sinha R.
        • Freedman N.
        Association of coffee drinking with mortality by genetic variation in caffeine metabolism: findings from the UK Biobank.
        JAMA Intern. Med. 2018; 178: 1086-1097
        • Massa J.
        • O'Reilly E.J.
        • Munger K.L.
        • Ascherio A.
        Caffeine and alcohol intakes have no association with risk of multiple sclerosis.
        Mult. Scler. 2013; 19: 53-58
        • O'Keefe J.H.
        • Bhatti S.K.
        • Patil H.R.
        • DiNicolantonio J.J.
        • Lucan S.C.
        • Lavie C.J.
        Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality.
        J. Am. Coll. Cardiol. 2013; 62: 1043-1051
        • Patsopoulos N.A.
        • Baranzini S.E.
        • Santaniello A.
        • et al.
        Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.
        Science. 2019; 365
        • Pekmezovic T.
        • Drulovic J.
        • Milenkovic M.
        • et al.
        Lifestyle factors and multiple sclerosis: a case-control study in Belgrade.
        Neuroepidemiology. 2006; 27: 212-216
        • Ponsonby A.L.
        • Lucas R.M.
        • Dear K.
        • et al.
        The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: the Ausimmune study.
        Mult. Scler. 2013; 19: 1717-1725
        • Ribeiro J.A.
        • Sebastião A.M.
        Caffeine and adenosine.
        J. Alzheimers Dis. 2010; 20: S3-15
        • Safarzadeh E.
        • Jadidi-Niaragh F.
        • Motallebnezhad M.
        • Yousefi M.
        The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis.
        Inflamm. Res. 2016; 65: 511-520
        • Smith G.D.
        • Ebrahim S.
        'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease.
        Int. J. Epidemiol. 2003; 32: 1-22
        • Smith G.D.
        • Lawlor D.A.
        • Harbord R.
        • Timpson N.
        • Day I.
        • Ebrahim S.
        Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology.
        PLoS Med. 2007; 4: e352
        • Wang T.
        • Xi N.N.
        • Chen Y.
        • et al.
        Chronic caffeine treatment protects against experimental autoimmune encephalomyelitis in mice: therapeutic window and receptor subtype mechanism.
        Neuropharmacology. 2014; 86: 203-211
        • Wijnands J.M.
        • Kingwell E.
        Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis.
        J. Neurol. Neurosurg. Psychiatry. 2016; 87: 453
        • Wutayd W.A.
        • Mohamed A.G.
        • Saeedi J.
        • Otaibi H.A.
        • Jumah M.A.
        Environmental exposures and the risk of multiple sclerosis in Saudi Arabia.
        BMC Neurol. 2018; 18: 86
        • Xu W.
        • Tan L.
        • Wang H.F.
        • et al.
        Meta-analysis of modifiable risk factors for Alzheimer's disease.
        J. Neurol. Neurosurg. Psychiatr. 2015; 86: 1299-1306
        • Zhong V.W.
        • Kuang A.
        • Danning R.D.
        • et al.
        . A genome-wide association study of bitter and sweet beverage consumption.
        Hum. Mol. Genet. 2019; 28: 2449-2457